Ertaczo Launch Could Help OrthoNeutrogena Rebuild Antifungal Market Share
Executive Summary
OrthoNeutrogena's topical athlete's foot treatment Ertaczo gives the company a chance to recapture market share lost to generic versions of another one of its antifungals, Spectazole